CytomX Therapeutics Inc. (CTMX)
NASDAQ: CTMX
· Real-Time Price · USD
1.93
0.17 (9.66%)
At close: Aug 15, 2025, 3:59 PM
1.93
0.26%
After-hours: Aug 15, 2025, 07:54 PM EDT
CytomX Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 23.52M | 18.88M | 5.74M | -6.53M | 13.79M | 837K | 2.99M | -1.09M | -3.31M | -27.95M | -23.3M | -24.18M | -23.89M | -26.23M | -22.58M | -19.24M | -15.55M |
Depreciation & Amortization | 36K | 413K | -817K | 459K | 467K | 486K | 484K | 610K | 595K | 608K | 623K | 610K | 602K | 675K | 680K | 677K | 674K |
Stock-Based Compensation | 2.01M | 1.88M | 2M | 1.88M | 1.91M | 2.55M | 1.23M | 2.37M | 2.41M | 2.57M | 2.69M | 4.49M | 3.37M | 3.54M | 3.16M | 3.42M | 3.03M |
Other Working Capital | n/a | -41.45M | 56.02M | -23.9M | -32.17M | -23.23M | -24.5M | -22.76M | -23.99M | 58.83M | -17.3M | -16.14M | -20.92M | -18.94M | -16.7M | -15.36M | -15.21M |
Other Non-Cash Items | n/a | 376K | -83.9M | -6.6M | 11.13M | 3.6M | 942K | 922K | -634K | 1.13M | 848K | 828K | 809K | 808K | 791K | 775K | 759K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -4.87M | -1.93M | -1.73M | n/a | n/a | n/a | n/a | n/a | -15K | 6K | 140K | 141K |
Change in Working Capital | n/a | -41.46M | 56.26M | -14.93M | -41.33M | -24.58M | -21.95M | -26.27M | 10.29M | 22.25M | -14.71M | -15.98M | -22.21M | -9.98M | -11.76M | -13.97M | -18.99M |
Operating Cash Flow | -21.04M | -19.91M | -20.73M | -19.55M | -26.05M | -21.96M | -18.24M | -25.18M | 9.35M | -1.39M | -33.84M | -34.24M | -41.31M | -31.19M | -29.7M | -28.2M | -29.94M |
Capital Expenditures | -119K | -80K | -19K | -96K | -115K | -266K | -9K | -517K | -48K | -182K | -410K | -412K | -736K | -245K | -268K | -114K | -982K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -13.13M | 42.93M | -100M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -19.79M | -49.78M | -12.31M | -93.39M | n/a | -111.87M | -92.93M | -73.44M | -146.59M | n/a | n/a | n/a | n/a | n/a | n/a | -99.9M | n/a |
Sales Maturities Of Investments | 50.5M | 65M | 30.5M | 115M | 45M | 125M | 50M | 100M | n/a | 100M | n/a | n/a | n/a | n/a | 10M | 54M | 59.99M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 45M | 13.13M | -42.93M | 100M | -146.59M | 100M | n/a | n/a | n/a | n/a | 10M | -45.9M | 59.99M |
Investing Cash Flow | 30.6M | 15.13M | 18.17M | 21.51M | 44.88M | 12.87M | -42.94M | 26.04M | -146.64M | 99.82M | -410K | -412K | -736K | -245K | 9.73M | -46.01M | 59.01M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 183K | -4.84M | 5.1M | 174K | 244K | 29.67M | 317K | n/a | 190K | n/a | 451K | 7K | 683K | 104K | 691K | 1.02M |
Financial Cash Flow | n/a | 2.25M | n/a | 5.1M | 174K | 244K | 29.67M | 317K | n/a | 190K | n/a | 451K | 7K | 683K | 104K | 691K | 108.73M |
Net Cash Flow | 9.55M | -2.52M | -2.56M | 7.06M | 19.01M | -8.85M | -31.51M | 1.18M | -137.29M | 98.61M | -34.25M | -34.2M | -42.04M | -30.75M | -19.86M | -73.52M | 137.81M |
Free Cash Flow | -21.16M | -19.99M | -20.75M | -19.64M | -26.16M | -22.23M | -18.25M | -25.7M | 9.3M | -1.58M | -34.25M | -34.65M | -42.05M | -31.44M | -29.97M | -28.31M | -30.92M |